"Prognosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations.
| Descriptor ID |
D011379
|
| MeSH Number(s) |
E01.789
|
| Concept/Terms |
Prognostic Factors- Prognostic Factors
- Factor, Prognostic
- Factors, Prognostic
- Prognostic Factor
|
Below are MeSH descriptors whose meaning is more general than "Prognosis".
- Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
- Diagnosis [E01]
- Prognosis [E01.789]
Below are MeSH descriptors whose meaning is more specific than "Prognosis".
This graph shows the total number of publications written about "Prognosis" by people in this website by year, and whether "Prognosis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 24 | 24 |
| 1996 | 0 | 22 | 22 |
| 1997 | 0 | 28 | 28 |
| 1998 | 0 | 37 | 37 |
| 1999 | 0 | 30 | 30 |
| 2000 | 0 | 47 | 47 |
| 2001 | 0 | 39 | 39 |
| 2002 | 0 | 41 | 41 |
| 2003 | 0 | 57 | 57 |
| 2004 | 0 | 56 | 56 |
| 2005 | 0 | 61 | 61 |
| 2006 | 0 | 76 | 76 |
| 2007 | 0 | 84 | 84 |
| 2008 | 0 | 84 | 84 |
| 2009 | 0 | 92 | 92 |
| 2010 | 0 | 99 | 99 |
| 2011 | 0 | 125 | 125 |
| 2012 | 0 | 100 | 100 |
| 2013 | 1 | 141 | 142 |
| 2014 | 1 | 165 | 166 |
| 2015 | 0 | 160 | 160 |
| 2016 | 4 | 151 | 155 |
| 2017 | 3 | 187 | 190 |
| 2018 | 1 | 202 | 203 |
| 2019 | 1 | 226 | 227 |
| 2020 | 1 | 210 | 211 |
| 2021 | 1 | 123 | 124 |
| 2022 | 0 | 60 | 60 |
| 2023 | 0 | 75 | 75 |
| 2024 | 0 | 117 | 117 |
| 2025 | 0 | 8 | 8 |
To return to the timeline,
click here.
Below are the most recent publications written about "Prognosis" by people in Profiles.
-
Impact of measurable residual disease clearance kinetics in patients with AML undergoing intensive chemotherapy. Blood Adv. 2025 Feb 25; 9(4):783-792.
-
Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions. Clin Cancer Res. 2025 Feb 03; 31(3):561-572.
-
The Landscape of ctDNA in Appendiceal Adenocarcinoma. Clin Cancer Res. 2025 Feb 03; 31(3):551-560.
-
Cardiac MRI Evaluation of Determinants and Prognostic Implications of Right Ventricular Dysfunction in Aortic Regurgitation. Radiol Cardiothorac Imaging. 2025 Feb; 7(1):e230389.
-
EASIX and m-EASIX predict CRS and ICANS in pediatric and AYA patients after CD19-CAR T-cell therapy. Blood Adv. 2025 Jan 28; 9(2):270-279.
-
Early-onset atherosclerotic cardiovascular disease. Eur J Prev Cardiol. 2025 Jan 27; 32(2):100-112.
-
The Association Between Thyroid Differentiation Score and Survival Outcomes in Papillary Thyroid Carcinoma. J Clin Endocrinol Metab. 2025 Jan 21; 110(2):356-363.
-
Association of opioid use with survival in patients with cancer treated with immune checkpoint inhibitors: it is time for evidence-based behaviors. Oncologist. 2025 Jan 17; 30(1).
-
Clinical and molecular characteristics of patients with brain metastasis secondary to pancreatic ductal adenocarcinoma. Oncologist. 2025 Jan 17; 30(1).
-
Neurocognitive outcomes and functional independence in adult survivors of childhood medulloblastoma diagnosed over 3 decades. Neuro Oncol. 2025 Jan 12; 27(1):254-266.